EcoDrugPlus

Melanocortin 1 Receptor

Ensembl ID : ENSIPUG00000006989
Gene Symbol: MC1R
3 Cross references
147 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSIPUG00000005798
Gene Symbol: MC3R
1 Cross references
138 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSIPUG00000002190
Gene Symbol: MC4R
1 Cross references
89 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSIPUG00000021267
Gene Symbol: MTNR1A
1 Cross references
183 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSIPUG00000001223
Gene Symbol: MTNR1AA
4 Cross references
8 Possible Orthologues:

Methionyl Aminopeptidase 2b

Ensembl ID : ENSIPUG00000023121
Gene Symbol: METAP2B
3 Cross references
220 Possible Orthologues:

Microtubule-Associated Protein Tau A

Ensembl ID : ENSIPUG00000015774
Gene Symbol: MAPTA
2 Cross references
202 Possible Orthologues:

Microtubule-Associated Protein Tau B

Ensembl ID : ENSIPUG00000018995
Gene Symbol: MAPTB
2 Cross references
152 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSIPUG00000020336
Gene Symbol: MAPK1
3 Cross references
211 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSIPUG00000015786
Gene Symbol: MAPK10
3 Cross references
87 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSIPUG00000005670
Gene Symbol: MAPK11
3 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSIPUG00000000798
Gene Symbol: MAPK14
4 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).